Skip to main content
Clinical Trials/NCT03416959
NCT03416959
Recruiting
Not Applicable

Prospective Bone Metastases Database

Istituto Ortopedico Rizzoli1 site in 1 country120 target enrollmentJanuary 1, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Neoplasm Metastasis
Sponsor
Istituto Ortopedico Rizzoli
Enrollment
120
Locations
1
Primary Endpoint
Clinical outcomes after treatment of long bone metastases with intramedullary nail versus endoprosthetic reconstruction
Status
Recruiting
Last Updated
9 months ago

Overview

Brief Summary

The aims of this study are to collect prospective data on the natural history of bone metastases (BMs) and skeleta related events (SREs),

Detailed Description

The aims of this study are to evaluate clinical and biological factors of patients with BMs after reconstruction with intramedullary fixation (IMN) or endoprosthetic reconstruction (EPR) with a specific focus on (1) the rate of complication or failure; (2) differences in complication rates by anatomic site; (3) functional results as assessed by the Musculoskeletal Tumor Society System (MSTS); (4) differences in complication rate between patients treated with INM versus EPR; and (5) differences in survival in patients with metastatic bone disease based on disease-specific, laboratory, and demographic information.

Registry
clinicaltrials.gov
Start Date
January 1, 2018
End Date
December 31, 2027
Last Updated
9 months ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Costantino Errani

MD, PhD.

Istituto Ortopedico Rizzoli

Eligibility Criteria

Inclusion Criteria

  • Patients with long bone metastases treated surgically with intramedullary nail or endoprosthetic reconstruction

Exclusion Criteria

  • Patients with bone metastases of the spine

Outcomes

Primary Outcomes

Clinical outcomes after treatment of long bone metastases with intramedullary nail versus endoprosthetic reconstruction

Time Frame: 24 months

The study includes the collection of clinical data (age, sex, Karnofsky score) and laboratory data related to the patient (erythrocyte sedimentation rate, C reactive protein, Alkaline phosphatase, white blood cells and hemoglobin) at the time of admission, data on the pathology (histotype, site of bone metastasis , presence of further skeletal or visceral metastases), type of surgery performed (stabilization versus resection).The objectives of this study is to examine clinical outcomes after after surgical treatment of bone metastases with a specific focus on differences in complication rate between patients treated with intramedullary nail versus endoprosthetic reconstruction

Secondary Outcomes

  • Survival in patients undergoing surgery for metastatic bone disease(24 months)

Study Sites (1)

Loading locations...

Similar Trials